Stavros G. Vizirgianakis is Director of Xtant Medical Holdings, Inc.. Currently has a direct ownership of 6.96 Million shares of XTNT, which is worth approximately $2.72 Million. The most recent transaction as insider was on Aug 15, 2024, when has been sold 748,648 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.96M
0% 3M change
12.05% 12M change
Total Value Held $2.72 Million

Stavros G. Vizirgianakis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2024
BUY
Grant, award, or other acquisition
-
748,648 Added 9.71%
6,961,773 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
-
217,770 Added 3.39%
6,213,125 Common Stock
Nov 15 2022
BUY
Grant, award, or other acquisition
-
144,639 Added 2.36%
5,995,355 Common Stock, $0.00000...
Oct 07 2022
BUY
Open market or private purchase
$1,087,133 $0.48 p/Share
2,264,861 Added 27.91%
5,850,716 Common Stock, $0.00000...
Aug 25 2022
BUY
Grant, award, or other acquisition
-
70,776 Added 1.94%
3,585,855 Common Stock, $0.00000...

Also insider at

BVS
Bioventus Inc. Healthcare
APYX
Apyx Medical Corp Healthcare
SGV

Stavros G. Vizirgianakis

Director
Belgrade, MT

Track Institutional and Insider Activities on XTNT

Follow Xtant Medical Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XTNT shares.

Notify only if

Insider Trading

Get notified when an Xtant Medical Holdings, Inc. insider buys or sells XTNT shares.

Notify only if

News

Receive news related to Xtant Medical Holdings, Inc.

Track Activities on XTNT